首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Dialysis without heparin in a patient with combined hereditary deficit in coagulation factor V and protein C.

【24h】

Dialysis without heparin in a patient with combined hereditary deficit in coagulation factor V and protein C.

机译：凝血因子V和蛋白C合并遗传性缺陷的患者无需肝素透析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association》 |1999年第3期|共2页
作者
Absy M;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科手术学;泌尿科学（泌尿生殖系疾病）;
关键词
Anticoagulants; Factor V Deficiency; Hemodialysis; Heparin; Protein C Deficiency; 抗凝药; 因子Ⅴ缺乏; 血液透析; 肝素; 蛋白质C缺乏;

机译：Anticoagulants;Factor V Deficiency;Hemodialysis;Heparin;Protein C Deficiency;抗凝药;因子Ⅴ缺乏;血液透析;肝素;蛋白质C缺乏;

相似文献

外文文献
中文文献
专利

1. Dialysis without heparin in a patient with combined hereditary deficit in coagulation factor V and protein C. [J] . Absy M Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 1999,第3期

机译：凝血因子V和蛋白C合并遗传性缺陷的患者无需肝素透析。
2. Oral tranexamic acid combined with low molecular weight heparin only during dialysis sessions successfully controlled chronic disseminated intravascular coagulation associated with aortic aneurysm and aortic dissection in a dialysis patient: a case report with literature review [J] . Eriko Eguchi Renal replacement therapy. . 2019,第1期

机译：口腔促甲酸与低分子量肝素相结合，仅在透析患者中成功控制慢性散发与透析患者主动脉瘤和主动脉夹层相关的血管内凝血：一个案例报告与文献综述
3. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII. [J] . Broijersen A, Hamsten A, Silveira A, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 1996,第2期

机译：吉非贝齐可降低合并高脂血症患者的凝血酶生成，而不会影响血浆纤维蛋白原，纤维蛋白凝胶结构或凝血因子VII。
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. Structural determinants for heparin binding in human coagulation factor XI [D] . Shikov, Sergei 2008

机译：肝素在人凝血因子XI中结合的结构决定因素
6. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin enhancement of inactivation of factor V by activated protein C. [O] . J Petäjä, J A Fernández, A Gruber, 1997

机译：肝素和活化蛋白C在体外的抗凝协同作用。肝素的新型抗凝机制的作用增强活化蛋白C对因子V的灭活作用。
7. Dialysis without heparin in a patient with combined hereditary deficit in coagulation factor V and protein C [O] . M. Absy 1999

机译：透析在患者中没有肝素的肝素，在凝血因子V和蛋白C中组合遗传缺陷

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号